Company / Depreciation & Amortization
AGIOS PHARMACEUTICALS, INC. Depreciation & Amortization History
FY2017-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$9.4M
FY2022
5-year range
$8.8M / $9.4M
FY2018-FY2022
Trend
+6.8%
vs FY2021
Sector context
#68 of 163
Health Care
What the data says
At $9M, AGIOS PHARMACEUTICALS, INC.'s depreciation & amortization ranks #96 of 163 in the Health Care sector. Depreciation & Amortization has fluctuated over the past 6 years, ranging from $6M in FY2018 to $9M in FY2022.
Based on SEC 10-K filings.
$9M in FY2022 with a 5-year CAGR of +7.9%.
Increased from $7M to $9M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +5.1%
- 5-Year CAGR
- +7.9%
- 10-Year CAGR
- -
Sector benchmark
#96 of 163 in Health CareTop 58% of 163This company $9.4M Sector average $219.4M
▼
-95.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.9%, indicating consistent growth.
- In FY2022, depreciation & amortization increased 6.8% year-over-year.
- Ranks #68 out of 163 companies in the Health Care sector.
- Lowest depreciation & amortization in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $9.4M | +6.8% |
| FY2021 | $8.8M | +22.2% |
| FY2020 | $7.2M | -11.0% |
| FY2019 | $8.1M | +41.7% |
| FY2018 | $5.7M | -11.3% |
| FY2017 | $6.4M | - |
| FY2016 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026